Hero Banner. Entresto® (sacubitril/valsartan) logo.
Hero Banner. Entresto® (sacubitril/valsartan) logo.

Prescribing information

All images are of fictional patients and healthcare practitioners

ENTRESTO® (sacubitril/valsartan) resources

In Ireland, ENTRESTO is indicated in adult patients for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF).1

Explore our resources designed to provide useful information on ENTRESTO and support with initiation and ongoing treatment

Preview image: Getting started with ENTRESTO: a two-step guide to prescribing.

Getting started with ENTRESTO: a two-step guide to prescribing

This guide provides a clear two-part approach to prescribing ENTRESTO. 

pdf
Download
Preview image: ENTRESTO initiation guide.

ENTRESTO initiation guide

This guide provides information on how to initiate treatment with ENTRESTO and what to do if your patient is currently taking an ACEi or ARB.

pdf
Download
Preview image: Quality of life infographic.

Quality of life infographic

This infographic provides key quality-of-life data from the PARADIGM-HF trial.

pdf
Download
Preview image: ENTRESTO reimbusement guide.

ENTRESTO reimbursement guide 

This guide provides details on the necessary criteria for reimbursement with ENTRESTO. Included are patient eligibility criteria and what supporting information may be required for reimbursement approval.

pdf
Download
Preview image: ESC and AHA/ACC guidelines for prescribing ENTRESTO.

ESC and AHA/ACC guidelines for prescribing ENTRESTO

This resource provides guidelines from the ESC and AHA/ACC on prescribing ENTRESTO. Information on patient type, how to start treatment and the follow-ups required are provided.

pdf
Download

Explore our resources designed to support your patients

Preview image: Your guide to ENTRESTO.

Your guide to ENTRESTO

This guide contains useful information for patients regarding their treatment with ENTRESTO, including why they have been prescribed ENTRESTO, how to take the medication and other helpful tips.

pdf
Download
Preview image: Your in-hospital guide.

Your in-hospital guide

This guide provides helpful information for patients who have been prescribed ENTRESTO whilst in hospital.

pdf
Download

ACC, American College of Cardiology; ACEi, angiotensin-converting enzyme inhibitor; AHA, American Heart Association; ARB, angiotensin receptor blocker; ESC, European Society of Cardiology; HFrEF, heart failure with reduced ejection fraction.

Reference

  1. ENTRESTO® (sacubitril/valsartan) Summary of Product Characteristics. Available on www.medicines.ie.

 

IE11526362 | April 2026

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance at www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.